Acer Therapeutics Inc.

NASDAQ:ACER

0.9 (USD) • At close September 17, 2024
Bedrijfsnaam Acer Therapeutics Inc.
Symbool ACER
Munteenheid USD
Prijs 0.66
Beurswaarde 0
Dividendpercentage 0%
52-weken bereik 0.55 - 4.56
Industrie Biotechnology
Sector Healthcare
CEO Mr. Christopher Schelling
Website https://www.acertx.com

An error occurred while fetching data.

Over Acer Therapeutics Inc.

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium

Vergelijkbare Aandelen

vTv Therapeutics Inc. logo

vTv Therapeutics Inc.

VTVT

13.87 USD

ARCA biopharma, Inc. logo

ARCA biopharma, Inc.

ABIO

28.8 USD

T2 Biosystems, Inc. logo

T2 Biosystems, Inc.

TTOO

0.359 USD

Immix Biopharma, Inc. logo

Immix Biopharma, Inc.

IMMX

2.18 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)